Literature DB >> 17621489

Intra-arterial thrombolysis in a 2-year-old with cardioembolic stroke.

Susan L Benedict1, Oliver K Ni, Peter Schloesser, Keith S White, James F Bale.   

Abstract

Recombinant tissue plasminogen activator, although the standard of care for the management of acute ischemic stroke in adults, is used infrequently in children. The authors describe the use of intra-arterial recombinant tissue plasminogen activator in a young child with embolic stroke. Thrombolysis restored flow to the affected middle cerebral artery and appeared to limit the extent of the infarction and the severity of the subsequent neurologic deficits.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17621489     DOI: 10.1177/0883073807300296

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  12 in total

1.  tPA contributes to impairment of ATP and Ca sensitive K channel mediated cerebrovasodilation after hypoxia/ischemia through upregulation of ERK MAPK.

Authors:  William M Armstead; John Riley; Douglas B Cines; Abd Al-Roof Higazi
Journal:  Brain Res       Date:  2010-12-20       Impact factor: 3.252

2.  Red blood cell-coupled tissue plasminogen activator prevents impairment of cerebral vasodilatory responses through inhibition of c-Jun-N-terminal kinase and potentiation of p38 mitogen-activated protein kinase after cerebral photothrombosis in the newborn pig.

Authors:  William M Armstead; Kumkum Ganguly; John Riley; J Willis Kiessling; Douglas B Cines; Abd A R Higazi; Sergei Zaitsev; Vladimir R Muzykantov
Journal:  Pediatr Crit Care Med       Date:  2011-11       Impact factor: 3.624

Review 3.  Pediatric stroke: the importance of cerebral arteriopathy and vascular malformations.

Authors:  Lauren A Beslow; Lori C Jordan
Journal:  Childs Nerv Syst       Date:  2010-07-13       Impact factor: 1.475

Review 4.  Signaling, delivery and age as emerging issues in the benefit/risk ratio outcome of tPA For treatment of CNS ischemic disorders.

Authors:  William M Armstead; Kumkum Ganguly; J W Kiessling; John Riley; Xiao-Han Chen; Douglas H Smith; Sherman C Stein; Abd A R Higazi; Douglas B Cines; Khalil Bdeir; Sergei Zaitsev; Vladimir R Muzykantov
Journal:  J Neurochem       Date:  2010-04       Impact factor: 5.372

Review 5.  The roles of anatomic factors, thrombophilia, and antithrombotic therapies in childhood-onset arterial ischemic stroke.

Authors:  Timothy J Bernard; Marilyn J Manco-Johnson; Neil A Goldenberg
Journal:  Thromb Res       Date:  2010-10-13       Impact factor: 3.944

6.  Assessment and treatment of stroke in children.

Authors:  Lori C Jordan
Journal:  Curr Treat Options Neurol       Date:  2008-11       Impact factor: 3.598

7.  A successful treatment of arterial ischemic stroke with stent insertion in a child with congenital heart disease.

Authors:  Hee Joon Yu; I-Seok Kang; Munhyang Lee; Keon-Ha Kim; Jeehun Lee
Journal:  Childs Nerv Syst       Date:  2012-07-31       Impact factor: 1.475

8.  Hyperacute therapies for childhood stroke: a case report and review of the literature.

Authors:  Jose Irazuzta; Kevin J Sullivan
Journal:  Neurol Res Int       Date:  2010-08-19

9.  Red blood cells-coupled tPA prevents impairment of cerebral vasodilatory responses and tissue injury in pediatric cerebral hypoxia/ischemia through inhibition of ERK MAPK activation.

Authors:  William M Armstead; Kumkum Ganguly; John W Kiessling; Xiao-Han Chen; Douglas H Smith; Abd A R Higazi; Douglas B Cines; Khalil Bdeir; Sergei Zaitsev; Vladimir R Muzykantov
Journal:  J Cereb Blood Flow Metab       Date:  2009-05-13       Impact factor: 6.200

10.  PAI-1-derived peptide EEIIMD prevents hypoxia/ischemia-induced aggravation of endothelin- and thromboxane-induced cerebrovasoconstriction.

Authors:  William M Armstead; John Riley; Douglas B Cines; Abd Al-Roof Higazi
Journal:  Neurocrit Care       Date:  2014-02       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.